"HIV-2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker.
| Descriptor ID |
D015498
|
| MeSH Number(s) |
B04.820.650.589.650.350.410
|
| Concept/Terms |
HIV-2- HIV-2
- Immunodeficiency Virus Type 2, Human
- Human Immunodeficiency Virus Type 2
- Human immunodeficiency virus 2
- Human T-Lymphotropic Virus Type IV
- LAV-2
- HIV-II
- HTLV-IV
- Human T Lymphotropic Virus Type IV
|
Below are MeSH descriptors whose meaning is more general than "HIV-2".
Below are MeSH descriptors whose meaning is more specific than "HIV-2".
This graph shows the total number of publications written about "HIV-2" by people in this website by year, and whether "HIV-2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2015 | 1 | 1 | 2 |
| 2020 | 3 | 1 | 4 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "HIV-2" by people in Profiles.
-
Early Diagnosis of HIV-1 and HIV-2 Using Cobas HIV-1/HIV-2 Qualitative Test: A Novel Qualitative Nucleic Acid Amplification Test for Plasma, Serum, and Dried Blood Spot Specimens. J Acquir Immune Defic Syndr. 2021 08 15; 87(5):1187-1195.
-
Design and methods of the prevalence and pharmacogenomics of tenofovir nephrotoxicity in HIV-positive adults in south-western Nigeria study. BMC Nephrol. 2020 10 16; 21(1):436.
-
The diagnostic accuracy of the HIV 1/2/subtype O Tri-line rapid test compared with ELISA: A pilot study. Oral Dis. 2020 Sep; 26 Suppl 1:161-164.
-
Comparison of Alere q whole blood viral load with DBS and plasma viral load in the classification of HIV virological failure. PLoS One. 2020; 15(5):e0232345.
-
Continuous quality monitoring in the field: an evaluation of the performance of the Fio Deki Reader™ for rapid HIV testing in South Africa. BMC Infect Dis. 2020 May 04; 20(1):320.
-
Reactivity of routine HIV antibody tests in children who initiated antiretroviral therapy in early infancy as part of the Children with HIV Early Antiretroviral Therapy (CHER) trial: a retrospective analysis. Lancet Infect Dis. 2015 Jul; 15(7):803-9.
-
Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency. J Virol. 2015 May; 89(10):5264-75.
-
High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination. Virology. 2009 May 10; 387(2):414-26.
-
Human immunodeficiency virus type 2 (HIV-2)/HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasma. J Virol. 2009 Feb; 83(3):1240-59.